Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01332032 · ClinicalTrials.gov registry record

Promoting Breast Cancer Screening in Non-adherent Women

A clinical trial of Breast Cancer, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
36,348
Enrollment target
1
Study location

NCT01332032 is a study of Breast Cancer that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 36,348 participants, above the 2,774-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (1210% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01332032, a study of Breast Cancer, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
36,348 participants
Enrollment target
1
Study location

Study Summary

This randomized study compares the effectiveness and cost-effectiveness of 3 proven methods of reaching out to women who are coming due for or who are overdue for a mammogram. The study originally embedded in a community healthcare plan and an associated community clinic, now accepts patients using the community clinic and 3 other health care plans. The study makes use of a complex computer driven reminder system. The study also will examine ways to improve the efficiency and sequencing of the interventions by identifying patient factors associated with intervention effectiveness.

Conditions Studied

Interventions

  • BEHAVIORAL Reminder Letter
  • BEHAVIORAL Reminder Call
  • BEHAVIORAL Counselor Call

Study Locations (1)

Massachusetts

  • Reliant Medical Group - Worcester

Trial Details

FieldValue
Enrollment Target 36,348 participants
Start Date 2009-07
Est. Completion 2015-05

What the Registry Record Tells You About NCT01332032

The ClinicalTrials.gov registry entry for NCT01332032 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36,348 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,774-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (1210% higher). The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Reminder Letter is the first listed.

NCT01332032 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01332032 about?

NCT01332032 is a clinical study titled "Promoting Breast Cancer Screening in Non-adherent Women". This randomized study compares the effectiveness and cost-effectiveness of 3 proven methods of reaching out to women who are coming due for or who are overdue for a mammogram. The study originally embedded in a community healthcare plan and an associated community clinic, now accepts patients using ...

What is the current status of trial NCT01332032?

This trial is currently completed. The enrollment target is 36,348 participants. The study started on 2009-07. Estimated completion is 2015-05.

What conditions does trial NCT01332032 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT01332032?

The interventions under investigation include: Reminder Letter (BEHAVIORAL), Reminder Call (BEHAVIORAL), Counselor Call (BEHAVIORAL).

Who is sponsoring clinical trial NCT01332032?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01332032 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.